Clin2
NCT06935344Possibly a fitRecruiting

Can genes predict ovarian cancer risk?

Ovarian Cancer

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a woman with a new diagnosis of epithelial ovarian or fallopian tube cancer.
  • Or you are a woman who has never been diagnosed with ovarian cancer.
  • You must not have any other active cancer besides ovarian cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07169396Recruiting
Genetic study for ovarian cancer treatments

This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.

Reggio Emilia
NCT06324175Recruiting
Spatial radiogenomics study for ovarian cancer

This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.

Roma
NCT00005095Recruiting
Ovarian cancer risk study: specimens and health data

This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.

Chicago, Illinois
NCT07532434Recruiting
Risk-Reducing Surgery for Hereditary Ovarian Cancer

This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.

Beijing, Beijing Municipality
NCT06925126Not yet recruiting
Recurrence score test for ovarian cancer using exosomes

This study is testing a new way to predict if ovarian cancer will come back after treatment. By looking at tiny particles called exosomes in your blood, researchers hope to create a score that can guide future care.

NCT02288676Recruiting
Genetic testing to help diagnose ovarian or uterine cancer earlier

This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.

Montreal, Quebec

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.